Explore our work
We respond to policy consultations and inquiries to make sure the real-life experiences of people affected by blood cancer are properly understood by those making decisions about healthcare, research, and support services. Consultations and inquiries are one of the main ways governments and organisations gather views before making changes, so it’s important that they hear directly from the people who will be most affected.
We also produce policy reports and analyse data to understand how we can drive change for the blood cancer community. By sharing evidence, patient stories, and expert insight, we help highlight what’s working, what isn’t, and where change is needed.
Explore our work to see how we’re helping influence decisions and drive meaningful improvements.
Read our work
- Key Facts Booklet: We've put together a booklet with the key facts about blood cancer (pdf). We use these facts in our policy and influencing work.
- Cross border care: Read our submission to the UK Government's Welsh Affairs Committee's inquiry on cross border healthcare arrangements to see how we shared the experiences of the blood cancer community in Wales (pdf).
- NHS Workforce Plan: The UK Government is due to publish its 10 Year NHS Workforce Plan for England. Read our contribution to the consultation and how we called for greater support for the blood cancer workforce (pdf).
- Joint briefing with BSH: We produced the following workforce briefing with the British Society for Haematology to bring together our joint expertise to address key questions (pdf).
- National Cancer Plan for England: The Plan was published on 4th February 2026. Read our consultation response (pdf) to see how we reflected the voices of the blood cancer community in the development of the plan. We also published a blog setting out how the plan impacts the blood cancer community.
- NHS 10 Year Health Plan: The 10 Year Health Plan was published on 3rd July 2025 and our blog set outs what the Plan means for people with blood cancer. In our submission (pdf), we worked hard to ensure the voices of the blood cancer community were heard by the Government as it planned its future vision of the NHS.
- UK Blood Cancer Action Plan: In 2024 we published our UK Blood Cancer Action Plan (pdf) which made 17 recommendations to improve blood cancer survival in the UK.
- Lord O'Shaughnessy's review of commercial clinical trials: In 2023, the Government commissioned an independent review into commercial clinical trials in the UK, led by Lord James O’Shaughnessy. We were pleased to take part in the consultation, ensuring that the experiences and needs of the blood cancer community were represented. Read our response to the consultation(pdf).
- Raise the profile, reduce the harm: Blood cancer is the fifth most common cancer, but low awareness means people affected are paying the price. Read our Raise the profile, reduce the harm report (pdf).
Join our Policy Collective
Sign up to our Policy Collective to receive regular updates on our access to treatments project, as well as other areas of our policy and influencing work.
To sign up, complete our involvement network form and tick the 'policy and influencing' check box.
More about our Policy and Influencing work
Policy and Influencing main page
Return to the policy and influencing main page to find out more about our work.
UK Blood Cancer Action Plan
Our Action Plan reveals shocking data about blood cancer survival in the UK. We need healthcare professionals and those affected by blood cancer to turn our set of recommendations into a reality.
Access to treatments
We know access to new, innovative blood cancer treatments varies across the UK. Find out what we’re doing to make access equal for everyone.
Access to clinical trials
Everyone diagnosed with blood cancer should have the opportunity to take part in a suitable clinical trial, regardless of their ethnicity, where they live or their socioeconomic background. Find out what we’re doing to increase access to clinical trials.